INR is used to guide warfarin therapy, not to measure or adjust the effect of a direct oral anticoagulant. True or false?
3 Direct Oral Anticoagulants Online Quiz Questions
Use this free practice quiz with 20 questions to review 3 Direct Oral Anticoagulants, test your knowledge, and prepare for your next test or exam.
The specific reversal agent for dabigatran is .
For acute DVT or PE treatment, which pair of DOACs is started after an initial course of parenteral anticoagulation?
- A
Apixaban and rivaroxaban
- B
Dabigatran and edoxaban
- C
Apixaban and edoxaban
- D
Rivaroxaban and dabigatran
In what month and year did the manufacturer end U.S. commercial sales of andexanet alfa? Enter the month and year in YYYY-MM format.
Complete the statements: Dabigatran directly inhibits . Apixaban, rivaroxaban, and edoxaban directly inhibit .
Which organ function is especially important to assess because impaired clearance can increase DOAC exposure?
Select all accurate statements about strong drug inducers and DOACs.
- A
Rifampin and carbamazepine can reduce exposure to some DOACs and potentially weaken anticoagulation.
- B
Rifampin and carbamazepine reliably increase apixaban exposure and therefore require a lower dose.
- C
Strong combined P-gp and CYP3A4 inducers such as rifampin and carbamazepine should generally be avoided with apixaban or rivaroxaban.
- D
Strong inducers should generally be combined with apixaban to prevent bleeding.
A normal PT/INR or aPTT result always rules out a clinically relevant DOAC level. True or false?
- A
True
- B
False
For severe bleeding involving a factor Xa inhibitor in the U.S. situation described, which statement best reflects the recommended approach?
- A
Use idarucizumab as the specific antidote for apixaban and rivaroxaban.
- B
Use andexanet alfa, which remains available for U.S. commercial sale.
- C
Follow local emergency protocols; four-factor prothrombin complex concentrate may be considered, but it is not a specific antidote.
- D
Adjust the dose to reach a target INR.
Select all uses of DOACs described in the material.
- A
Preventing stroke in nonvalvular atrial fibrillation
- B
Treating DVT or PE and preventing recurrence
- C
Treating bacterial infections
- D
Preventing clots after certain orthopedic surgeries
What key safety advice should a clinician give a patient taking a DOAC about taking the medicine, warning signs, other medicines, and upcoming procedures?
Which statement best explains why one DOAC should not be substituted for another milligram for milligram?
- A
All DOACs have identical approved uses and can be substituted milligram for milligram.
- B
Indications and dosing are drug-specific, so DOACs are not interchangeable milligram for milligram.
- C
The same dose of any DOAC produces the same effect in every patient.
- D
Only the drug name differs; dosing and use are otherwise uniform.
In the context of clot treatment, what does DVT stand for?
A patient taking a DOAC feels better and plans to stop the medicine without consulting the prescriber. Is this a safe plan?
- A
True
- B
False
A patient’s DOAC is being changed to a different DOAC. Which approach is appropriate when selecting the new dose?
- A
Replace the current DOAC with the same milligram dose of another DOAC.
- B
Check the new drug’s specific indication and dosing rather than substituting milligram for milligram.
- C
Use the same dose only if both drugs are taken once daily.
- D
Choose the replacement dose by targeting the patient’s INR.
A patient taking a DOAC asks which unusual stool appearance should be reported promptly as a possible warning sign. Enter the stool appearance.
A patient taking a DOAC asks whether they can start over-the-counter ibuprofen for pain. What is the safest advice?
- A
Start ibuprofen, but take it several hours apart from the DOAC.
- B
Use aspirin instead of the DOAC on days when pain is worse.
- C
Do not start ibuprofen unless the prescriber approves it.
- D
Take naproxen routinely because it does not affect bleeding risk.
A patient with impaired kidney function is being assessed for DOAC treatment. Which statement should guide the medication review?
- A
Review kidney function carefully, particularly if the patient is taking dabigatran.
- B
Use the INR to determine whether kidney function is adequate for any DOAC.
- C
Kidney function is not relevant because DOACs are cleared only by the liver.
- D
Assess kidney function only when a patient takes apixaban.
A patient taking a DOAC asks whether the dose should be changed to reach a target INR. Which response is appropriate?
- A
Increase the DOAC dose until the INR reaches the warfarin target.
- B
Use the INR to confirm that the DOAC has reached its full effect.
- C
Reduce the DOAC dose whenever the INR is within the warfarin target range.
- D
Do not adjust the DOAC to reach a target INR; INR guides warfarin therapy.
A patient is starting treatment for a new DVT. Which statement about the initial treatment plan is accurate?
- A
All four drugs require an initial course of parenteral anticoagulation.
- B
Dabigatran and edoxaban require an initial parenteral course, while apixaban and rivaroxaban have oral regimens that can begin without it.
- C
Only apixaban and rivaroxaban require an initial parenteral course.
- D
None of the four drugs can be used to treat acute DVT without an initial parenteral course.
Related study packs and tools
- Quiz
1 Principles of Fundamental Care
A medium-difficulty quiz on applying person-centred principles of fundamental care, including dignity, choice, safety, independence, infection prevention, and observation.
- Study guide
1 Scene Assessment and Emergency Priorities
Learn how to make an emergency scene safer, rapidly identify and address immediate threats to life, prioritize patients, and reassess as conditions change.
- Study guide
2 Immediate Stabilization Decisions
A practical guide to recognizing immediate threats, providing appropriate first aid while EMS is coming, and prioritizing emergency transport decisions.
- Quiz
3 Prioritizing Hypotheses
A medium-difficulty quiz on generating plausible hypotheses, comparing urgency and risk, explaining priorities, and revising them as patient cues change.
NCLEX-RN Clinical JudgmentUpdated - Quiz
4 Destination Decisions and Transport Planning
A medium-difficulty quiz on selecting and communicating an appropriate patient destination using patient needs, facility capabilities, travel conditions, and local protocols.
- Study guide
4 Destination Decisions and Transport Planning
Learn how to select and communicate a patient destination by matching clinical risk and likely care needs to facility capability, travel conditions, and local EMS protocols.
- Study guide
4 Patient Identification
Learn how to verify a patient’s identity safely before care, what to do when information does not match, and how to proceed when a patient cannot confirm their identity.
- Study guide
4 Prioritize Hypotheses
Learn how to compare plausible explanations for a client’s findings and prioritize the concern that poses the greatest immediate risk.
- Quiz
5 Generate Solutions
A medium-difficulty quiz on setting measurable patient goals and selecting, implementing, and evaluating interventions that address the priority problem.
- Study guide
5 Urinary and Bowel Elimination
Learn how to support safe, comfortable, and independent toileting, provide elimination and skin care, and recognize changes that require reporting or urgent attention.
- Study guide
6 Take Action
Learn how to implement safe, prioritized nursing interventions, respond to deterioration, communicate concerns, and reassess patient outcomes.
- Quiz
8 Integrated NGN Case Studies
Practice applying the NGN clinical judgment steps, using common item formats, and interpreting client changes.